Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2013
A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases
Richard J Lee, Philip J Saylor, M Dror Michaelson, et al.
Journal of Exposure Science & Environmental Epidemiology
|
April 30, 2015
Airborne asbestos take-home exposures during handling of chrysotile-contaminated clothing following simulated full shift workplace exposures
Jennifer Sahmel, Christy A Barlow, Shannon Gaffney, et al.
Urologic Oncology
|
May 19, 2023
Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancer
Keyan Salari, Jason Kowitz, Jeffrey Twum-Ampofo, et al.
Oncotarget
|
April 19, 2014
Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells
Claire B Pollock, Sara McDonough, Victor S Wang, et al.
Practical Radiation Oncology
|
April 24, 2025
Combination Metastasis-Targeted External Beam Radiation Therapy With <sup>177</sup>Lu-PSMA-617 in Patients With Advanced Castration-Resistant Prostate Cancer
Sedra Mohammadi, Isabella R Pompa, Veronica Haberman, et al.
European Urology
|
January 2, 2017
Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy
Ross E Krasnow, Michael Drumm, Hannah J Roberts, et al.
European Urology
|
January 14, 2017
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
Nicholas J Giacalone, William U Shipley, Rebecca H Clayman, et al.
Oncotarget
|
February 9, 2018
Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells
Lucas Tricoli, Aisha Naeem, Erika Parasido, et al.
BJU International
|
July 21, 2015
Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapy
Richard J Lee, Katherine S Tzou, Michael G Heckman, et al.
Urologic Oncology
|
December 17, 2013
Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy
Gregory R Pond, Giuseppe Di Lorenzo, Andrea Necchi, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2013
A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases
Richard J Lee, Philip J Saylor, M Dror Michaelson, et al.
Journal of Exposure Science & Environmental Epidemiology
|
April 30, 2015
Airborne asbestos take-home exposures during handling of chrysotile-contaminated clothing following simulated full shift workplace exposures
Jennifer Sahmel, Christy A Barlow, Shannon Gaffney, et al.
Urologic Oncology
|
May 19, 2023
Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancer
Keyan Salari, Jason Kowitz, Jeffrey Twum-Ampofo, et al.
Oncotarget
|
April 19, 2014
Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells
Claire B Pollock, Sara McDonough, Victor S Wang, et al.
Practical Radiation Oncology
|
April 24, 2025
Combination Metastasis-Targeted External Beam Radiation Therapy With <sup>177</sup>Lu-PSMA-617 in Patients With Advanced Castration-Resistant Prostate Cancer
Sedra Mohammadi, Isabella R Pompa, Veronica Haberman, et al.
European Urology
|
January 2, 2017
Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy
Ross E Krasnow, Michael Drumm, Hannah J Roberts, et al.
European Urology
|
January 14, 2017
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
Nicholas J Giacalone, William U Shipley, Rebecca H Clayman, et al.
Oncotarget
|
February 9, 2018
Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cells
Lucas Tricoli, Aisha Naeem, Erika Parasido, et al.
BJU International
|
July 21, 2015
Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapy
Richard J Lee, Katherine S Tzou, Michael G Heckman, et al.
Urologic Oncology
|
December 17, 2013
Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy
Gregory R Pond, Giuseppe Di Lorenzo, Andrea Necchi, et al.
Page
of 10